Kawashima Taichi, Miyazawa Yukimasa, Sakata Haruhito, Matsubara Hisahiro, Ryu Munemasa, Ochiai Takenori
Dept. of Academic Surgery, Graduate School of Medicine, Chiba University.
Gan To Kagaku Ryoho. 2005 Jun;32(6):825-8.
A 51-year-old woman was admitted to our hospital with a chief complaint of left axillary tumors. No such tumors were detected in bilateral breasts by ultrasonic tomography, mammography, computed tomography, and magnetic resonance imaging. The core needle biopsy from the left axillary lymph node was examined, and the specimen revealed an occult breast cancer, because the microscopic findings resembled the breast cancer organization and immunochemistry revealed positivity of the estrogen receptor. The radical left axillary dissection was operated. Tamoxifen and FEC 100 6 cycles were selected as adjuvant treatment. At one year after operation, she has no recurrence. Carcinoma cells had portedly been recognized in the mammary gland with 82.7% of the cases who had undergone mastectomy for occult breast cancer. However, in many cases, the patient's consent for mastectomy was not obtained like as in this case, and the choice of treatment is often difficult. We considered that the case's accumulation was necessary to verify the possibility of the mastectomy omission to an occult breast cancer, presented the case report.
一名51岁女性因左腋窝肿物为主诉入院。通过超声断层扫描、乳腺X线摄影、计算机断层扫描和磁共振成像,双侧乳房均未检测到此类肿物。对左腋窝淋巴结进行了粗针活检,标本显示为隐匿性乳腺癌,因为显微镜下表现类似于乳腺癌组织,免疫化学显示雌激素受体阳性。进行了左侧腋窝根治性清扫术。选择他莫昔芬和FEC 100方案进行6个周期的辅助治疗。术后一年,她没有复发。据报道,在接受隐匿性乳腺癌乳房切除术的患者中,82.7%的病例在乳腺中发现了癌细胞。然而,在许多情况下,如本病例一样,未获得患者对乳房切除术的同意,治疗选择往往很困难。我们认为有必要积累病例以验证隐匿性乳腺癌省略乳房切除术的可能性,现报告该病例。